Development of non-donor-specific HLA antibodies after kidney transplantation: Frequency and clinical implications

Contributions to Nephrology

Volumn 162, Issue , 2009, Pages 107-116

  Briggs, D ^a   Zehnder, D ^b   Higgins, R M ^c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN;

BIOSYNTHESIS; BLOOD; DONOR; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; REVIEW;

HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; TISSUE DONORS;

EID: 59849119970     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000170843     Document Type: Article

References (25)

1. Barnardo MC, Harmer AW, Shaw OJ, Ogg GS, Bunce M, Vaughan RW, Morris PJ, Welsh KI: Detection of HLA-specific IgG antibodies using single recombinant HLA alleles: the MonoLISA assay. Transplantation 2000;70:531-536.
2. Harmer AW, Heads AJ, Vaughan RW: Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients. Transplantation 1997;63: 1828-1832.
3. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI: Single human leucocyte antigen flow cytometry beads for accurate identification of human leucocyte antigen antibody specificities. Transplantation 2003;75:43-49.
4. Pei R, Lee J, Chen T, Rojo S, Terasaki PI: Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999;60:1293-1302.
5. Sumitran-Karuppan S: The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies. Transplantation 1999;68:502-509.
6. Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003;3:1488-1500.
7. Harmer A, Briggs D, Dyer P, Fuggle S, Martin S, Smith J, Taylor C, Vaughan R: Guidelines for the Detection and Characterisation of Clinically Relevant Antibodies in Solid Organ Transplantation. Leeds, British Transplantation Society & British Society for Histocompatibility and Immunogenetics, 2004.
8. Cai J, Terasaki PI, Mao Q, Pham T, El-Awar N, Lee JH, Rebellato L: Development of non-donor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant 2006;6:2947-2954.
9. Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou J P, Bignon JD: Frequency and clini- cal implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005;16:2804-2812.
10. Mao Q, Terasaki PI, Cai J, Briley K, Catrou P, Haisch C, Rebellato L: Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 2007;7:864-871.
11. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J: 'Natural' HLA alloantibodies found in non-alloimmunized healthy males. Transplantation (in press).
12. Terasaki PI: Humoral theory of transplantation. Am J Transplant 2003;3:665-673.
13. Palmer A, Bewick M, Kennedy L, Welsh K, Taube D: Anti-HLA antibodies following the transplantation of highly sensitised renal allograft recipients. Transplant Proc 1989;21:766-767.
14. Bevan DJ, Carey BS, Fallon M, Higgins RM, Hendry BM, Bewick M: Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients. Transplant Proc 1997;29:1448.
15. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS: The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990;49:85-91.
16. Montgomery RA, Zachary AA, Racusen LC, et al: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch positive recipients. Transplantation 2000;70:887-895.
17. Higgins R, Hathaway M, Lowe D, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Zehnder D, Chen K, Krishnan N, Hamer R, Briggs D: Blood levels of donor-specific HLA antibodies after renal transplantation; resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007;84:876-884.
18. Higgins RM, Raymond NT, Krishnan NS, Veerasamy M, Rahmati M, Lam FT, Kashi H, West N: Acute rejection after renal transplantation is reduced by about 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. Transplantation 2004;77:469-471.
19. Lovegrove E, Pettigrew GJ, Bolton EM, Bradley JA: Epitope mapping of the indirect T-cell response to allogeneic class I MHC: sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production. J Immunol 2001;167:4338-4344.
20. Hanvesakul R, Maillere B, Briggs D, Baker R, Larché M, Ball S: Indirect recognition of T-cell epitopes derived from the α3 and transmembrane domain of HLA-A2. Am J Transplant 2007;7: 1148-1157.
21. Hathaway M, Adams DH: Demonstration that donor-specific nonresponsiveness in human liver allograft recipients is both rare and transient. Transplantation 2004;77:1246-1252.
22. Matinlauri IH, Kyllönen LE, Eklund BH, Koskimies SA, Salmela KT: Weak humoral posttrans-plant alloresponse after a well-HLA-matched cadaveric kidney transplantation. Transplantation 2004;78:198-204.
23. Mizutani K, Terasaki P, Hamdani E, Esquenazi V, Rosen A, Miller J, Ozawa M: The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007;7:1027-1031.
24. Lefaucheur C, Nochy D, Hill GS, Suberbielle-Boissel C, Antoine C, Charron D, Glotz D: Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007;7:832-841.
25. Cai J, Terasaki PI, Bloom DD, Torrealba JR, Friedl A, Sollinger HW, Knechtle SJ: Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation 2004;78:919-924.